Navigation Links
New Drug Found To Benefit Patients With Osteoarthritis

Osteoarthritis is a degenerative joint disease and one of the oldest and most common types of arthritis. It happens when the joint’s cartilage breaks down and the bones rub against each other causing pain and loss of movement.//

An international, multi-center study shows an effective treatment for osteoarthritis is the COX2 inhibitor lumiracoxib, also known as Prexige. The drug was found to reduces gastric complications that often occur with other treatments.

It is common for doctors to prescribe non-selective non-steroidal anti-inflammatory drugs to reduce pain in patients with osteoarthritis . However, the side effects of these drugs can cause gastrointestinal ulcer complications that can be fatal. A recent study evaluated gastrointestinal and cardiovascular safety of the COX2 inhibitor lumiracoxib compared to the NSAIDs naproxen, commonly known as Aleve, and ibuprofen.

The study included 18,325 osteoarthritis patients who were randomized to receive lumiracoxib, naproxen or ibuprofen for one year. Results show the risk of ulcer complications was reduced among patients on lumiracoxib compared to patients on naproxen. However, this benefit did not apply for patients who were also taking aspirin. Researchers also found lumiracoxib showed a three- to four-fold reduction in ulcer complication compared to naproxen without an increase risk of a cardiovascular problem.

Thus researchers say their findings show that lumiracoxib is an appropriate treatment for patients with osteoarthritis.

Page: 1

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:

(Date:11/27/2015)... ... , ... ProSidebar: Fashion is a set of 30 kinetic edge ... video editors can easily add an informative sidebar to any FCPX production. Create ... featuring self-animating drop zones, lines, bars, and text with the ease of FCPX's drag ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group ... group of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , November 27, 2015 ... is set to go online. The potential to save ... is vast and far from fully exploited as yet. ... patient health records, either via mobile tablet or directly ... --> ) --> ...
(Date:11/27/2015)... Niederlande, November 27, 2015 ... bei fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   --> Ein ... fortgeschrittenem Krebs.   Clinical Cancer Research ... Clinical Cancer Research vom 6. November ...
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
Breaking Medicine Technology: